Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting [Corrigendum]
Perrone V, Sangiorgi D, Buda S, Degli Esposti L. Int J Chron Obstruct Pulmon Dis. 2016;11:2749–2755.
On page 2749, Patients and methods section, line 5, “between January 1, 2009 and December 31, 2011 (inclusion period)” should have read “between January 1, 2010 and December 31, 2011 (inclusion period)”.
On page 2750, Cohort definition section, line 4, “between January 1, 2011 and December 31, 2011 (inclusion period)” should have read “between January 1, 2010 and December 31, 2011 (inclusion period)”.
Read the original article here.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]